Comparison Between the Effect of Infiltration Between the Popliteal Artery and Capsule of the Knee Block Versus Selective Tibial Nerve Block for Postoperative Analgesia in Patient Undergoing Total Knee Arthroplasty. A Prospective Randomized Study
Comparison Between i Pack Block and Post Tibial Nerve Block
1 other identifier
interventional
70
1 country
1
Brief Summary
Comparison Between the Effect of Infiltration Between the Popliteal Artery and Capsule of the Knee Block Versus Selective Tibial Nerve Block for Postoperative Analgesia in Patient Undergoing Total Knee Arthroplasty.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2022
CompletedFirst Submitted
Initial submission to the registry
July 22, 2022
CompletedFirst Posted
Study publicly available on registry
July 26, 2022
CompletedJuly 26, 2022
December 1, 2021
6 months
July 22, 2022
July 22, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Total morphine consumption
24 hours
24 hours post operative
Study Arms (2)
Adductor canal block with Ipack block
ACTIVE COMPARATORAdductor canal block with selective tibial nerve block
ACTIVE COMPARATORInterventions
Ultrasound guided
Eligibility Criteria
You may qualify if:
- Patients with osteoarthritis scheduled for a primary either partial or total knee arthroplasty • Patients aged 40-80 years with a body mass index of 18-36 kg/ m2 and an American Society of Anesthesiologists functional status of I-III Planned use of regional anesthesia
You may not qualify if:
- Patients younger than 40 years old and older than 80years.
- Hepatic or renal insufficiency.
- Patients undergoing general anesthesia.
- Allergy or intolerance to one of the study medications.
- BMI \> 36
- Diabetes
- ASA of IV
- Chronic opioid use (taking opioids for longer than 3 months, or daily oral morphine equivalent of \>5mg/day for one month)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tanta Universitylead
Study Sites (1)
Tanta university
Tanta, Egypt
Study Officials
- PRINCIPAL INVESTIGATOR
Marwa Abogabal, MD
Tanta University
- PRINCIPAL INVESTIGATOR
Wafaa Abdelwahed, MD
Tanta University
- PRINCIPAL INVESTIGATOR
Wafaa Abdelsalam, MD
Kafr Elsheikh university
- PRINCIPAL INVESTIGATOR
Shaimaa Zahra
Tanta University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer
Study Record Dates
First Submitted
July 22, 2022
First Posted
July 26, 2022
Study Start
January 1, 2022
Primary Completion
June 15, 2022
Study Completion
June 30, 2022
Last Updated
July 26, 2022
Record last verified: 2021-12